A previous report demonstrated that plasma SAM concentrations were related to higher fasting insulin levels, the homeostasis model assessment of insulin resistance, and the tumor necrosis factor α in a cross-sectional study that involved subjects with metabolic syndrome (Lind et al., 2018). The gene discussed is INS; the disease is metabolic syndrome.